US Stocks
/
Jasper Therapeutics, Inc. Share Price

Jasper Therapeutics, Inc. Share Price

NASDAQ: JSPR | Micro Cap
$0.69
-$0.01 (-2.1%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Jasper Therapeutics, Inc. Stock Performance

Open
$0.70
Prev. Close
$0.71
Circuit Range
N/A
Day Range
$0.66 - $0.70
Year Range
$0.32 - $2.94
Volume
1,266
Average Traded
$0.68

Jasper Therapeutics, Inc. Share Price Today

As of 29 August 2026, Jasper Therapeutics, Inc.'s share price is $0.69. The stock opened at $0.70, compared to its previous close of $0.71. During today's trading session, Jasper Therapeutics, Inc.'s share price traded between $0.66 and $0.70, with an average price of $0.68. Over the past 52 weeks, the stock has recorded a high of $2.94 and a low of $0.32. In terms of performance, Jasper Therapeutics, Inc.'s share price has declined by 49.70% over the last six months and is down 75.30% on a year-on-year basis.

Jasper Therapeutics, Inc. Share Price Chart

$0.66$0.70
L
Show Current Price
H

Jasper Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.30M
PE Ratio (TTM)
-0.18
Dividend Yield
N/A
EPS (TTM)
$-3.95
Revenue (TTM)
N/A
Return On Equity (TTM)
-1826.09%
Profit Margin
N/A
Debt to Equity
3.18
Quarterly Earnings Growth YoY
-0.53%

Jasper Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$13.73M-$14.58M-$18.64M-$21.24M-$26.72M-$18.74M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-6.23%-27.80%-13.97%-25.81%29.89%

Jasper Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$37.69M-$64.47M-$71.27M-$75.80M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-71.06%-10.55%-6.36%

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

Jasper Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.61
$0.70
+10.92%
Jul 2026
$0.41
$0.63
+48.36%
Jun 2026
$0.85
$0.43
-49.47%
May 2026
$0.93
$0.84
-9.55%
Apr 2026
$0.89
$0.93
+7.25%
Mar 2026
$1.33
$0.87
-37.03%
Feb 2026
$1.48
$1.38
-5.80%
Jan 2026
$1.83
$1.47
-19.51%
Dec 2025
$1.80
$1.82
+0.00%
Nov 2025
$2.09
$1.82
-19.47%
Oct 2025
$2.40
$2.26
-5.44%
Sep 2025
$2.79
$2.39
-14.95%

JSPR Share Price FAQs

What is Jasper Therapeutics, Inc. share price today?

chevron-up
Jasper Therapeutics, Inc. share price today is $0.69 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Jasper Therapeutics, Inc. stock?

chevron-up
The 52 week high of Jasper Therapeutics, Inc. stock is $2.94, while the 52 week low is $0.32 as of 29 Aug '26.

What is JSPR's market capitalisation today?

chevron-up
JSPR market capitalisation is $13.30M as of August 29, 2026, at 2:28 pm IST.

What is JSPR's net income for the last quarter?

chevron-up
JSPR's net income for the last quarter is -0.02B USD.

What is the 5 year returns of JSPR?

chevron-up
The 5 year returns of JSPR is -99.30% as on 29 Aug '26.

What is the high & low stock price of JSPR today?

chevron-up
JSPR stock price hit a high of $0.70 and low of $0.66 as of 29 Aug '26.

Can I buy JSPR shares in India?

chevron-up
Yes. You can buy JSPR in India by opening an international trading account.